" class="no-js "lang="en-US"> XRHealth and Reducept Offer Patients Virtual Reality Therapy for Pain Management - Pharmtech Focus
Wednesday, February 01, 2023

XRHealth and Reducept Offer Patients Virtual Reality Therapy for Pain Management

XRHealth, the leader in extended reality and therapeutic applications, announced today that they are working with Reducept to expand their offering to patients for virtual reality therapy for pain management. The virtual reality technology provides exercises that train people suffering from chronic pain on how to gain control over pain, potentially reducing the need for medication.

The XRHealth and Reducept partnership was designed for individuals experiencing ongoing chronic pain. The Reducept VR Game trains the users’ brain to create its own pain medication via digital psychological pain treatment. The pain management app provides immersive visual journeys and education through a gamified narrative. The app also offers targeted behavioral experiments, and applies evidence-based techniques from acceptance and commitment therapy and cognitive behavioral therapy through 3D virtualization of the body.

The CDC reports that over 20% of adult Americans suffer from chronic pain and 7.4% experience high impact chronic pain. The XRHealth and Reducept collaboration aims to help many people regain control of their lives. Reducept trains the brain to deal with pain differently by combining the scientific insights on pain education, psychology and digital therapy, and teaches users about pain, how it affects their body and gives practical tools to apply in everyday life.  Reducept is an award-winning software, having won the United Nations World Summit Award, Accenture Healthtech Innovation Challenge Award 2019, the International Serious Play Awards 2019 and Game Bakery Awards: Best Serious Game 2020.  Today, Reducept has helped over 2500 patients learn more about their pain and get better control over their lives.

“We would like to provide people in pain with enjoyable, satisfying and sustainable pain treatment. The great thing about Reducept is that it combines several patient-focused techniques clinically proven to reduce the negative impact of pain on quality of life. We are excited to join XRHealth to make Reducept treatment accessible on their platform,” says Margryt Fennema, CEO of Reducept.

XRHealth provides remote care to patients globally with a variety of conditions, including pain management, and is covered by most major health insurance companies as well as Medicare. One of the unique features that VR therapy provides is that users can utilize therapy from the comfort of their home while data and healthcare progress is shared with their doctors in real-time so that medical providers can adjust therapy, as needed.

“Chronic pain can often be debilitating for people and the medication required to control the pain can be both addictive and have unpleasant side effects for patients,” says Eran Orr, CEO of XRHealth. “Virtual reality can provide a realistic and immersive experience for users to train their brain to gain control over their body and produce their own medication, potentially eliminating dependency on drugs while providing the much necessary alleviation from the pain. Users feel empowered by the new-found control over their mind and the influence it has on their body. “

People In This Post

Companies In This Post

  1. Sherlock Biosciences Acquires Sense Biodetection Advancing CRISPR-Based Diagnostics for Consumers Read more
  2. Genoscience Pharma receives FDA Orphan Drug Designation for ezurpimtrostat to treat HepatoCellular Carcinoma (HCC) Read more
  3. AviadoBio Announces Appointment of Jeff Goater as Chair of the Board of Directors Read more
  4. Ellipses Pharma Announces FDA Approval of IND Application for EP0042 for Patients With Acute Myeloid Leukaemia Read more
  5. Ariceum Therapeutics Appoints Radioligand Expert, Germo Gericke, as Chief Medical Officer Read more